Active surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly common and effective way to manage certain early-stage cancers, including those in ...
Mar 28, 2024
0
0
Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, especially those with ...
Jan 26, 2024
0
1
A 10-year follow-up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision-making in terms of treatments and side effects for a diverse population.
Jan 23, 2024
0
15
Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoids or delays treatment like surgery or radiation ...
Jan 22, 2024
0
0
Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long-term risk of cervical cancer, suggests a study published by The BMJ today.
Nov 29, 2023
0
14
In the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect of using the inexpensive, safe, and widely used diabetes drug to prevent ...
Nov 6, 2023
0
2
"Me encontraron càncer en la pròstata," my father told me. They found cancer in my prostate.
Aug 9, 2023
0
2
The number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with ...
Apr 3, 2023
0
8
For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in the Journal ...
Jan 10, 2023
0
4
Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.
Sep 22, 2022
0
4
